Literature DB >> 6614539

Use of continuous infusion versus intermittent bolus administration of fentanyl or ketamine during outpatient anesthesia.

P F White.   

Abstract

The intraoperative and postoperative effects of fentanyl and ketamine administered continuously by infusion were compared with those produced by conventional intermittent bolus administration in 100 patients. After a standardized induction with thiopental 4 mg/kg intravenously, patients received either fentanyl (50 micrograms boluses vs. 2 micrograms/ml infusion) or ketamine (25 mg boluses vs. 1 mg/ml infusion) as intravenous adjuvants to nitrous oxide, 70% in oxygen. With continuous infusion, the doses of fentanyl and ketamine required were decreased 45% and 43%, respectively. Similarly, the times to awakening were decreased significantly, 62% and 60%, in the fentanyl and ketamine infusion groups, respectively. Intraoperative side effects (e.g., hypoventilation, hypotension, rigidity) were less frequent in the fentanyl infusion (vs. bolus) group but did not differ in the ketamine groups. Trieger scores were consistent with a more rapid recovery in both infusion groups. Incidences of common postoperative side effects (e.g., nausea, vomiting, visual disturbances, dizziness) did not differ significantly between bolus and infusion groups. However, excessive sedation was noted in 48% and 52% of patients in the fentanyl and ketamine bolus groups, respectively, compared with 4% and 8%, respectively, in the infusion groups. Discharge times were decreased by 29% and 13% in the fentanyl and ketamine infusion groups, respectively. The author concludes that continuous infusion fentanyl (0.1 micrograms . kg-1 . min-1) or ketamine (50 micrograms . kg-1 . min-1) significantly decreases the drug dosage requirement, improves intraoperative conditions, and decreases recovery time compared with the traditional intermittent bolus technique.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6614539     DOI: 10.1097/00000542-198310000-00005

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  10 in total

1.  Anesthesiology-important advances in clinical medicine: outpatient anesthesia techniques: continuous intravenous infusion of anesthetic agents.

Authors:  P F White
Journal:  West J Med       Date:  1984-03

2.  Intraoperative anesthetic management of patients undergoing glomus tumor resection using a low-dose isoflurane-fentanyl technique.

Authors:  W S Jellish; J Murdoch; J Leonetti
Journal:  Skull Base Surg       Date:  1994

3.  Anticonvulsant therapy increases fentanyl requirements during anaesthesia for craniotomy.

Authors:  R Tempelhoff; P A Modica; E L Spitznagel
Journal:  Can J Anaesth       Date:  1990-04       Impact factor: 5.063

4.  Continuous intravenous analgesia with fentanyl or morphine after gynecological surgery: a cohort study.

Authors:  Andrea Russo; Domenico Luca Grieco; Francesca Bevilacqua; Gian Marco Anzellotti; Annamaria Scarano; Giovanni Scambia; Barbara Costantini; Elisabetta Marana
Journal:  J Anesth       Date:  2016-10-14       Impact factor: 2.078

5.  Ketamine anesthesia.

Authors:  J R Werther
Journal:  Anesth Prog       Date:  1985 Sep-Oct

Review 6.  Intravenous infusion anaesthesia and delivery devices.

Authors:  D R Miller
Journal:  Can J Anaesth       Date:  1994-07       Impact factor: 5.063

7.  General anesthetics: a comparative review of pharmacodynamics.

Authors:  S B Milam
Journal:  Anesth Prog       Date:  1984 May-Jun

8.  Comparison of continuous sufentanil and fentanyl infusions for outpatient anaesthesia.

Authors:  P Phitayakorn; B M Melnick; A F Vicinie
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

Review 9.  Ketamine: an update on the first twenty-five years of clinical experience.

Authors:  D L Reich; G Silvay
Journal:  Can J Anaesth       Date:  1989-03       Impact factor: 5.063

Review 10.  The Effects of Low-Dose Ketamine on Acute Pain in an Emergency Setting: A Systematic Review and Meta-Analysis.

Authors:  Eun Nam Lee; Jae Hoon Lee
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.